India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...

Progressive strengthening of public facilities is the only way to reach medical services to the population as a whole. “The best form of providing health protection would be to change the economic system which produces ill health, and to liquidate ignorance, poverty and unemployment. The practice of each individual purchasing his own medical care does not work. It is unjust, inefficient, wasteful and completely outmoded ... In our highly geared, modern...

-The Business Standard   The National Bank for Agriculture and Rural Development (Nabard) has recorded a 40 per cent growth in agriculture credit and rural development in Karnataka during 2011-12. It has extended farm credit of Rs 6,053 crore during the year. While the production credit refinance extended to cooperative banks and regional rural banks (RRBs) was Rs 3,775 crore, its finance to state government under the Rural Infrastructure Development Fund (RIDF)...

-The Economic Times   The national auditor is expected to stick to its controversial estimate of Rs 10.7 lakh crore as gains accrued to companies due to allocation of coal blocks on government discretion instead of auctioning them, an official in the Comptroller and Auditor General's (CAG) office said.  This is set to further embarrass the UPA government that has been mired in a series of controversies. "The report is not yet final,...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory Licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory Licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...